Skip to content

HIV-positive Africans as likely to access and benefit from HAART as Europeans in Swiss Cohort

Uncircumcised Indian men have 8 times higher HIV risk

Despite high rates of TB in HIV-positives, TB rates stable in HIV-negative S Africans with TB risk

BHIVA preparing HIV/TB treatment guidelines - comments sought

Man found guilty of English offence of grievous bodily harm after infecting sex partners with HIV

Less than 40% of HIV-positive Swiss cohort have CD4 cell count above 500 after four years of HAART

Don't use tenofovir, ddI, 3TC combination warns Gilead

Global Fund approves $359 million for AIDS

GSK gives pan-Africa license to South African firm

HAART continues to improve survival, but not all HIV risk groups benefit equally

Australian therapeutic vaccine shows promise in treatment interruption

New form of liposuction able to reduce buffalo hump - at least in the short term

One in four UK HIV diagnoses are missed says BHIVA

Condoms close to 100% effective, says EU in Vatican rebuttal

Grand Challenges offer opportunities for HIV research funding

Fos-amprenavir gets marketing approval in US, but once daily dose not recommended for PI-experienced

Gilead issues tenofovir/ddI/3TC warning for European doctors - follows US warning last week

Quarter of women with undetectable viral load have HIV in genital fluids